Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inspire Medical Systems (INSP) Receivables (2017 - 2025)

Historic Receivables for Inspire Medical Systems (INSP) over the last 9 years, with Q4 2025 value amounting to $119.7 million.

  • Inspire Medical Systems' Receivables rose 2860.7% to $119.7 million in Q4 2025 from the same period last year, while for Dec 2025 it was $119.7 million, marking a year-over-year increase of 2860.7%. This contributed to the annual value of $119.7 million for FY2025, which is 2860.7% up from last year.
  • According to the latest figures from Q4 2025, Inspire Medical Systems' Receivables is $119.7 million, which was up 2860.7% from $108.0 million recorded in Q3 2025.
  • Over the past 5 years, Inspire Medical Systems' Receivables peaked at $137.7 million during Q2 2025, and registered a low of $21.6 million during Q1 2021.
  • In the last 5 years, Inspire Medical Systems' Receivables had a median value of $67.5 million in 2023 and averaged $68.5 million.
  • As far as peak fluctuations go, Inspire Medical Systems' Receivables skyrocketed by 14341.96% in 2021, and later surged by 354.23% in 2024.
  • Over the past 5 years, Inspire Medical Systems' Receivables (Quarter) stood at $34.2 million in 2021, then skyrocketed by 79.14% to $61.2 million in 2022, then surged by 46.8% to $89.9 million in 2023, then increased by 3.54% to $93.1 million in 2024, then rose by 28.61% to $119.7 million in 2025.
  • Its Receivables stands at $119.7 million for Q4 2025, versus $108.0 million for Q3 2025 and $137.7 million for Q2 2025.